Loading clinical trials...
Loading clinical trials...
An Efficacy and Safety Study of JYP0061 Tablets in Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Trial
Conditions
Interventions
JYP0061 15 mg
JYP0061 30 mg
+1 more
Locations
1
China
Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Start Date
December 27, 2023
Primary Completion Date
February 10, 2026
Completion Date
October 10, 2026
Last Updated
March 20, 2025
NCT07321951
NCT03057860
NCT07344051
NCT05590585
NCT05899816
NCT04921345
Lead Sponsor
Guangzhou JOYO Pharma Co., Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions